National Institutes of Health: HIV Seropositivity trials

The registry lists 21 HIV Seropositivity studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 6Phase 2 3Phase 3 1Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Thinking and Memory Problems in People With HIVRecruitingNCT01875588
• Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral TherapyCompletedNCT00367458Phase 2Results posted
• Prevalence and Incidence of Lassa Virus Infection in Southern MaliCompletedNCT03783143
• Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaActive, not recruitingNCT03519464Phase 2
• The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215CompletedNCT01034800
• Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected AdultsCompletedNCT00776412
• Motivation and Patch Treatment for HIV-positive SmokersCompletedNCT00551720Phase 3
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)TerminatedNCT00459693Not applicable
• A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean CountriesCompletedNCT00341302
• Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSCompletedNCT00106795
• Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal FatCompletedNCT00009555Phase 4
• Safety and Tolerability of the Vaginal Gel PRO 2000/5CompletedNCT00006207Phase 1
• Effects of Potent Antiretroviral Therapy on Kaposi s SarcomaCompletedNCT00006171
• Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive PatientsCompletedNCT00001474Phase 2
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsCompletedNCT00001102
• A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsCompletedNCT00000772Phase 1
• A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARCCompletedNCT00000735Phase 1
• A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ CellsCompletedNCT00000667Phase 1
• Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00000664Phase 1
• A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive IndividualsCompletedNCT00000648Not applicable
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive IndividualsCompletedNCT00000633Phase 1